Long-term management of abetalipoproteinaemia. Possible role for vitamin E.
- 1 March 1977
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 52 (3) , 209-214
- https://doi.org/10.1136/adc.52.3.209
Abstract
Eight patients with abetalipoproteinaemia have been followed for 3-4 to 15-8 years. Management included dietary fat restriction and supplements of the fat-solublevitamins A, E, and K. In the 3 oldest patients serial studies of retinal and neurological function suggest that treatment with large doses of oral vitamin E may have delayed the development or progression of the neurological and retinal lesions.This publication has 20 references indexed in Scilit:
- PRESENT KNOWLEDGE OF VITAMIN EPublished by Oxford University Press (OUP) ,2009
- The relative importance of the factors involved in the absorption of vitamin E in childrenGut, 1974
- AbetalipoproteinemiaAnnual Review of Medicine, 1972
- The cardiac lesions in Bassen-Kornzweig syndrome: Report of a case, with autopsy findingsThe American Journal of Medicine, 1970
- Neutral lipids of plasma and adipose tissue in a-betalipo-proteinaemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 1970
- Abnormalities of High Density Lipoproteins in Abetalipoproteinemia*Journal of Clinical Investigation, 1967
- A- -lipoproteinaemiaArchives of Disease in Childhood, 1965
- A-β-lipoproteinaemia with special reference to the visual defectExperimental Eye Research, 1964
- Demyelinating central nervous system disease, macular atrophy and acanthocytosis (Bassen-Kornzweig syndrome)The American Journal of Medicine, 1964
- ON HAVING NO BETA-LIPOPROTEIN A SYNDROME COMPRISING A-BETA-LIPOPROTEINÆMIA, ACANTHOCYTOSIS, AND STEATORRHŒAThe Lancet, 1960